Nextgen Biomed Ltd (NXGN.TA)
- Previous Close
54.50 - Open
52.50 - Bid 50.80 x --
- Ask 51.00 x --
- Day's Range
50.30 - 59.50 - 52 Week Range
1.02 - 125.00 - Volume
242,440 - Avg. Volume
28,318 - Market Cap (intraday)
3.857M - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
-- - EPS (TTM)
-0.58 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
www.nextgen-biomed.comRecent News: NXGN.TA
View MorePerformance Overview: NXGN.TA
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NXGN.TA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NXGN.TA
View MoreValuation Measures
Market Cap
3.96M
Enterprise Value
4.12M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-728.92%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-4.89M
Diluted EPS (ttm)
-0.58
Balance Sheet and Cash Flow
Total Cash (mrq)
35k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-522.88k